Knocking at the brain’s door: intravital two-photon imaging of autoreactive T cell interactions with CNS structures by Kawakami, Naoto & Flügel, Alexander
REVIEW
Knocking at the brain’s door: intravital two-photon imaging
of autoreactive T cell interactions with CNS structures
Naoto Kawakami & Alexander Flügel
Received: 8 March 2010 /Accepted: 22 June 2010 /Published online: 11 July 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Since the first applications of two-photon mi-
croscopy in immunology 10 years ago, the number of
studies using this advanced technology has increased
dramatically. The two-photon microscope allows long-
term visualization of cell motility in the living tissue with
minimal phototoxicity. Using this technique, we examined
brain autoantigen-specific T cell behavior in experimental
autoimmune encephalitomyelitis, the animal model of
human multiple sclerosis. Even before disease symptoms
appear, the autoreactive T cells arrive at their target organ.
There they crawl along the intraluminal surface of central
nervous system (CNS) blood vessels before they extrava-
sate. In the perivascular environment, the T cells meet
phagocytes that present autoantigens. This contact activates
the T cells to penetrate deep into the CNS parenchyma,
where the infiltrated T cells again can find antigen, be
further activated, and produce cytokines, resulting in
massive immune cell recruitment and clinical disease.
Keywords Two-photon imaging.Autoimmunity.CNS
EAE—an animal model of MS and tissue-specific
autoimmunity
Multiple sclerosis (MS) is an autoimmune disease that is
characterized by inflammation of the central nervous
system (CNS). Although the detailed mechanism of MS
is largely unknown, autoreactive T cells seem to play a
central role in the pathogenesis of the disease. While a
small number of autoreactive T cells also exist in healthy
humans, they seemingly do not infiltrate into the CNS
under normal conditions. The CNS has been considered
an immune-privileged organ because it has no profes-
sional antigen-presenting ce l l s( A P C s )a n dn ol y m p h a t i c
vessels. However, this situation changes dramatically
under inflammatory conditions, when lymphocytes in-
cluding autoreactive T cells infiltrate into the CNS, and
brain resident cells start to express molecules of the
major histocompatibility complex (MHC) [1, 2]. Animal
models of the disease have proven to be very powerful
tools to study how autoreactive T cells start to attack the
CNS [3]. Experimental autoimmune encephalomyelitis
(EAE) is one of the most well-established and intensively
studied animal models of human MS. EAE is either
induced by active immunization with brain antigens
emulsified in complete Freund’s adjuvant [4]o rb y
adoptive transfer of brain antigen-specific T cells [5].
Various antigens are commonly used to induce EAE, for
example, myelin basic protein (MBP) [6], myelin oligo-
dendrocyte glycoprotein (MOG) [7], or proteolipid protein
(PLP) [8].
Lymphocytes have been shown to play an important
role in EAE induction [9]. The adoptive transfer of lymph
node (LN) cells derived from the CNS antigen-immunized
animals into naïve recipients induces EAE. T cell
depletion methods later showed that the T cell fraction
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DOI 10.1007/s00281-010-0216-xindeed facilitates this disease transfer [10]. In the 1980s,
Ben-Nun et al. [5, 11] isolated the inducing element,
autoantigen-specific T cells. MBP-specific T cells were
cloned and expanded in vitro. After intravenous transfer of
an MBP-specific T cell line, the animals developed
paralytic symptoms, which occurred after a clinic-free
period of 3–4d a y s .
Once the antigen-specific encephalitogenic T cells were
established, many researchers tried to study the infiltration
process into the CNS at a single-cell level. Hickey et al., for
example, used histological methods [12], transferring in-
vitro-activated T cells into syngeneic rats. Spinal cord
cryosections were stained with antibodies against T cell
antigens. Although they could detect early T cell infiltra-
tion, they could not distinguish if the T cells originated
from the injected T cell population or from endogenous
lymphocytes. To overcome this problem, they transferred
MBP-specific Lewis T cells into Dark Agouti rats; exploit-
ing allogenic markers, the transferred cells could be
identified in the CNS of the recipient animals. Subsequent-
ly, radio isotope labeling (reviewed in [13]) was used:
T cells were labeled with
111In, and the radioactivity was
measured in various organs 6 h after transfer and in this
way T cell accumulation in the CNS was demonstrated in
EAE rats. Although these methods could determine the
amount of T cells in the organs, it was not possible to see
each infiltrated cell.
In an earlier work, we established genetically labeled
antigen-specific T cells for chasing a single cell [14]. In
brief, green fluorescence protein (GFP) gene-coded cDNA
was transduced into T cells using a retroviral vector. These
GFP-labeled MBP-specific T cells (TMBP-GFP cells) keep
their encephalitogenicity like nonlabeled MBP-specific
T cells. Using TMBP-GFP cells, we demonstrated that they
appeared in perithymic lymph nodes on day 1 posttransfer
(p.t.) and in the spleen on day 2 p.t. before they arrived at
the spinal cord on day 3 p.t. [15]. During their itinerary,
TMBP-GFP cells underwent phenotypic changes, i.e., they
downregulated activation markers and upregulated chemo-
kine receptors. These steps appear to be important for
migration into the CNS. As the analysis of the TMBP-GFP
cells in the animal was only of “snap shot” quality, we
subsequently used “real-time” analysis with two-photon
microscopy.
Fluorescent labeling techniques for in vivo imaging
To analyze a defined population of cells, labeling must be
done to distinguish other cell populations. For this purpose,
fluorescent labeling techniques are most commonly used.
Obviously, labeled cells have to be excited for efficient
imaging. Therefore, excitation laser power and labeling
techniques are equally important for high-quality imaging.
Although two-photon excitation is not very phototoxic,
higher-power lasers can cause damage. Since the two-
photon laser is infrared, it can be used to warm up the
sample (like a halogen heater). With better labeling, laser
power and subsequent unnecessary tissue damage can be
reduced and penetration depth increased. The common dyes
for intravital imaging are listed in Table 1.
Long used in the analysis of cell division [16],
carboxyfluorescein succinimidyl ester (CFSE) is one of
most common chemical dyes for intravital imaging [17].
CFSE has a similar spectrum to that of fluorescein
isothiocyanate (FITC). It is colorless and passively pene-
trates into living cells, where it is cleaved by esterases and
becomes fluorescent. CFSE binds intracellular amines of
the cellular proteins and acts as a long-term stable stain for
cells. However, at too high concentration, it can disturb
cellular function and may even kill the cells. Because CFSE
binds stably to cellular proteins, labeled proteins are
distributed evenly in the daughter cells which will then
have half the fluorescence signal of the parental cell. Thus,
CFSE is a very suitable fluorochrome for quantification of
cell proliferation. At the same time, this property of the dye
makes long-term imaging of actively dividing cells imprac-
ticable. 5-Chloromethylfluorescein diacetate (CMFDA) for
green color and 5-(and-6)-(((4-chloromethyl)benzoyl)ami-
no)tetramethylrhodamine (CMTMR) for red color represent
alternative chemical dyes. CMFDA and CMTMR bind to
thiols on proteins but still share the disadvantage of CFSE,
i.e., they are diluted with cell divisions.
Stable labeling is necessary for long-term observation of
dividing cells. For this purpose, cDNA coding for fluores-
cence protein (FP) is often inserted into the DNA of cells to
establish stably transduced cells or transgenic animals. In
general, this causes a weaker labeling than with chemical
dyes, but since proteins are continuously synthesized,
labeling is stable for a long time, even in dividing cells.
One of the most famous and most common FPs is GFP.
Originally cloned from jelly fish, it was optimized for
brightness and eukaryotic expression by nucleotide modi-
fication [18, 19]. GFP matures in the cells without any
cofactors and is quite stable. Most importantly, GFP can be
expressed in living cells without disturbing cellular func-
tions. In addition, ubiquitously GFP-expressing transgenic
mice [20] and rats [21] have been established. GFP was
modified further at the nucleotide level to obtain blue, cyan,
and yellow fluorescence protein (BFP, CFP, and YFP,
respectively) [22]. The classical red FP (RFP) was cloned
from a coral [23]. It can be expressed equally as well as
GFP, but it tends to multimerize, thus prohibiting its use as
fusion protein. Furthermore, at high concentrations, it might
exert cell toxicity. Recently, monomeric RFP and less toxic
variants have been developed and employed for cell tracing
276 Semin Immunopathol (2010) 32:275–287in vivo. An interesting variant of RFP is Kaede. It can
change from green to red after irradiation with UV light
[24]. Since this photo conversion is stable for a long time, it
can be very useful for tracking a particular single cell in
vivo. Meanwhile, the repertoire of FPs has considerably
widened, thereby making it possible to choose custom-
tailored fluorochrome combinations for individual projects
(reviewed in [25]).
During the intravital imaging, visualizing the environ-
mental structure is very informative. For example, collagen
fibers are visualized by second harmonic generation (SHG)
[26]. SHG is a nonlinear coherent scattering process that
conserves energy. SHG emission wavelength is always half
the excitation wavelength. The blood vessel structures
are commonly visualized by intravenous application of
fluorescence-conjugated dextrans [27]. The molecular size
of the dextran used must be large enough (>70 kDa) to
prevent leakage from the blood vessels. Dextran fills the
lumina of blood vessels but fails to mark endothelial cells.
However, some phagocytic cells in the vessel surroundings
can take up any dextran leaking out of the vessels and
become fluorescent [28]. An attractive alternative label for
the blood stream came with the commercial introduction of
quantum dots (Q-dots), composed of a semiconductor
nanocrystal with a special coating that improves its half-
life in the circulation. Q-dots are efficiently excited at a
broad range of wavelengths, have extraordinary photo-
stability, and yield a strong fluorescence signal with a
narrow emission spectrum [29]. Once excited by any
wavelength, it emits a strong fluorescent signal. Since it is
Table 1 Spectra of commonly used fluorescent markers for in vivo imaging
2-photon excitation Conventional excitation Emission
Fluorescence proteins, jellyfish-derived eBFP 780 380 440
eCFP 860–920 433 475
eGFP 880–930 488 509
eYFP 960 513 527
Fluorescence proteins, coral-derived Kaede (before conversion) 730 508 518
Kaede (after conversion) 730 572 582
tdTomato 900–1,000 554 581
DsRed 930–990 558 583
mCherry 760 or 900–1,000 587 610
Chemical dyes CMF2HC 780–800 371 464
CFSE 780–820 492 517
CMFDA 800 492 517
FITC 780–800 494 520
CMTMR 780–820 541 565
SNARF 700–810 563 639
CMTPX 780–800 577 602
Texas Red 780–920 595 615
Calcium indicator Indo-1 700 346 475
Indo-1 with Ca2+ 700 330 401
Fura-2 700–850 363 512
Fura-2 with Ca2+ 700–850 335 505
Fura-4F 700–850 366 511
Fura-4F with Ca2+ 700–850 336 505
TN-XXL 800 433 475
TN-XXL with Ca2+ 800 433 527
Visualization of organelles Hoechst 780 350 461
DAPI 700 358 461
FM 1–43 830 480 565
Rhodamine 123 780–860 507 529
Dil 700 549 565
Sulforhodamine 101 840–890 586 605
DiD 780 644 665
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imaging. Moreover, there are dyes which label specific
cells; for example, sulforhodamine101 labels only astro-
cytes [30].
Recently, a series of “functional” dyes have become
available for visualizing intracellular calcium concentra-
tions. New dyes are being developed for not only cell
tracking but also visualizing cellular function such as
intracellular signaling in vivo.
Two-photon laser scanning microscopy
During conventional (“single photon”) excitation using
confocal microscopy, a fluorescent molecule absorbs a
photon with a specified energy. For example, a molecule of
GFP absorbs a photon of 488-nm wavelength and becomes
excited. After nonradiative relaxation, the molecule of GFP
then emits a 509-nm photon and returns to basal energy
state. In contrast, during two-photon excitation, a GFP is
theoretically excited by two photons of 976-nm wavelength
(488 nm×2), i.e., half the amount of energy of one photon
with 488 nm (Fig. 1a). These two photons of 976-nm
wavelength should arrive in a small volume (less than 1 f
liter) over a short time period (scale of attoseconds) to
achieve a two-photon effect. In such a situation, the energy
of two independent photons can “fuse” to excite a GFP
fluorochrome. Afterwards, GFP emits fluorescence as in the
one-photon excitation. Fluorescent molecules show a wider
excitation spectrum by two-photon excitation; for example,
optimal excitation wavelength for GFP is shorter than
900 nm instead of 976 nm. Therefore, two fluorescence
molecules with distinct excitation wavelengths, e.g., GFP
and RFP, can both be excited by one wavelength of two-
photon laser. In nature, a two-photon effect rarely occurs
due to the enormous density of photons required for its
generation. For example, under sunlight conditions, a
rhodamine B fluorochrome will experience a one-photon
excitation every second. In contrast, a two-photon effect
will occur only once in ten million years [31].
Therefore, specialized lasers had to be developed for
practical realization of two-photon laser scanning micros-
copy (TPLSM). Contrary to conventional lasers which
produce photons spontaneously, these pulsed lasers can
accumulate photons, emitting them from time to time. During
this process, photons are concentrated within a 10-ns time
window into 100 fs, which yields a 10
5-fold higher peak
power, without changing the average power. These con-
densed photons are further focused by the objective lens of
the microscope, leading to their maximal accumulation at the
focal point. The theory of the two-photon effect was
established in the early 1930s by Göppert-Mayer (reviewed
in [32]). As high-power energy was required, the effect was
experimentally confirmed only in 1961. Winfried Denk was
the first to apply two-photon microscopy to biology in 1990
[33]. The resulting great breakthrough in biology research
was due to the suitability of TPLSM for in vivo imaging.
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Fig. 1 a, b Comparison between conventional one-photon excitation
versus two-photon excitation. a During conventional excitation, a
photon activates a fluorescence molecule (left), whereas during two-
photon excitation, two photons can sum up their energy to activate a
fluorescence molecule (right). After nonradiative relaxation (dotted
line), a fluorescence molecule emits fluorescence, which is common in
both conventional and two-photon excitation. b Conventional laser
can excite a fluorescence molecule on its way (indicated as black area
in left). However, fluorescent molecules can be activated only at the
focus point since two-photon effect needs energy accumulation
(indicated as black circle in right). c CNS intravital imaging setup.
The animal is anesthetized and respiration is controlled during the
entire imaging session. Additionally, body temperature is kept at 37°C
and ECG is monitored. Two-photon laser is routed to xy-scanner via
EOM to control laser power. Thereafter, laser is focused by objective
lens and reaches the sample. Emission is collected by the objective
lens and detected by NDDs which are located immediately behind it
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there is little excitation outside the focal volume (Fig. 1b).
Consequently, the fading of fluorescence is minimized. In
addition, the pinhole for cutting fluorescence out of the focal
plane in confocal microscopy is no longer necessary. Instead,
TPLSM should detect all fluorescence signals regardless of
whether they are scattered or not. Since scattering happens
very frequently when imaging deep inside the tissue, the
collection of scattered photons from the sample increases the
detection sensitivity of the fluorescence signal. Furthermore,
longer wavelength laser light (such as with two-photon
excitation) is scattered less and therefore can penetrate more
deeply into tissues. All in all, TPLSM is characterized by
lower phototoxicity and higher penetration depth than one-
photon microscopy such as confocal and fluorescence
microscopy.
Confocal and two-photon systems equipped with photo-
multipliers as detectors can detect signals from one par-
ticular point simultaneously. A three-dimensional (3D)
picture is obtained by scanning the laser through the sample
in the x and y dimensions and then acquiring serial optical
sections in a z-stack using a z-stepper motor to change the
plane of focus in the sample. The time required to generate
a 3D picture crucially depends on the speed of the scanner.
Although newly developed resonance scanners reach
velocities of up to 16,000 Hz (16,000 lines in 1 s), they
are too slow to detect rapid biological events like
intracellular calcium signaling. Thanks to newly developed
techniques, two-photon lasers can now be split into
multiple beams using sets of mirrors in the scanning unit
while still retaining enough peak power. Scanning can be
speeded up when the latter setup is combined with highly
sensitive CCD detectors that can distinguish signals from
multiple excited points [34].
Interesting technical innovations continue to be devel-
oped. For example, Helmchen et al. have miniaturized two-
photon microscopy for mounting on living rats [35]. Using
this system, they imaged the blood vessel structure in the
brain and the calcium influx in neuronal cells. Although
two-photon microscopy allows deep penetration, the depth
is limited to approximately 1 mm. To overcome this
limitation and allow deeper imaging, the gradient index
(GRIN) lens was developed [36]. The GRIN lens has a
needle-like shape and is attached to the surface of the
objective lens. It permits imaging at a depth of 2 mm in the
living animal with only minimal invasion.
Intravital imaging of immune reactions
A TPLSM hallmark study in immunology research was
published in 2002 by Miller et al. [37]. By imaging naïve
T and B cells in explanted lymph nodes, they compared
T and B cell motility and demonstrated that the lympho-
cytes showed a “random walk” behavior in the absence of
specific antigen. However, the T cells dramatically changed
their motility pattern in the presence of antigen. T cells
formed clusters, i.e., showed antigen recognition [37].
Concurrently, Bousso et al. demonstrated CD4/CD8
double-positive T cells by imaging them in thymic
reaggregation culture [38]. Here, they showed MHC-
dependent interactions between T cells and thymic stromal
cells. Moreover, they also described long- and short-term
dynamic interactions.
Although these well-documented studies had a very
great impact in the field, they were not true in vivo studies.
In 2003, Miller et al. performed the first intravital imaging
of T cells [17], demonstrating naïve CD4 T cell motility in
inguinal lymph nodes. T cells moved up to 25 μm/min and
averaged a speed of 11 μm/min; interestingly, their
locomotion behavior and their velocity resembled the one
which had been observed before in explanted lymph nodes
[37]. In later study, Bajénoff et al. showed that stromal cells
guide T cells and keep them in the T cell zone of lymph
node [39]. This suggests that T cell motility can be
influenced by the surrounding structure. Subsequently,
Mempel et al. [27] visualized the contact between naïve
T cells (CD4
+ or CD8
+) and dendritic cells (DC) within
popliteal lymph nodes. They proposed a three-step model of
antigen encounter between T cells and DCs. According to
this model, T cells make a series of short contacts with DCs
at an early stage of antigen recognition (<8 h after antigen
recognition). Thereafter (<24 h), T cells make a long stable
contact and start to secrete cytokines. Finally, T cells detach
from DCs and then start to move and make a short series of
contacts (<48 h). During this stage, T cells proliferate.
Similar multistep T–DC interactions were observed by Miller
et al. using antigen-specific naïve CD4
+ T cells [40].
Furthermore, Shakhar et al. showed that this model was
observed under priming and tolerance conditions [29].
Worbs et al. detected molecular signs of Tcell motility in
LN. They showed that the CCR7 ligands, CCL19 and
CCL21, stimulate T cell motility [41]. T cells derived from
CCR7-deficient mice exhibited reduced motility. In addi-
tion, T cells in plt/plt mice, which lack CCR7 ligands, also
exhibited a slower motility but were rescued by CCL21.
Hugues et al. focused on CD8
+ T cells [42]. They
demonstrated that the types of contact determine the
functional outcomes. Short contacts induce tolerance,
whereas long contacts activate T cells. Although they used
lymph node explants, Bousso et al. showed the dynamic
scanning process of dendritic cells and their interactions
with CD8
+ T cells [43]. Slower than T cells, dendritic cells
moved within the lymph nodes and made contacts with up
to 500 T cells per hour and maximally ten T cells at same
time. Miller et al., who used CD4
+ T cells instead of CD8
+
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CD4 T cells per hour and maximally 250 T cells
simultaneously.
After interacting with dendritic cells, activated CD8
+ T
cells show cytotoxic activity. Boissonnas et al. described
how the arresting of CD8
+ T cells on tumor cells was
antigen dependent [45]. Additionally, they demonstrated
how the CD8
+ T cells resumed migrating after killing their
target. Breart et al. showed in vivo killing of mouse tumors
by adoptively transferred antigen-specific CD8
+ T cells
[46]. They found that a CD8 T cell needed 6 h to kill one
target tumor cell. Recently, Kim et al. demonstrated the
motility of lymphocytic choriomeningitis virus infection-
specific CD8
+ T cells at brain meninges during the viral
infection [47]. They showed how CD8
+ T cells arrest the
MHC-class-I-dependent pathway. They also illustrated
leakage of the blood brain barrier (BBB) and showed how
subsequently myelomonocytic cells infiltrated the CNS.
Intravital microscopy has been used to image not only
T cell–DC interactions but also other combinations of
interactions. Todokoro et al., for example, showed how
regulatory T cells shorten interactions between primary
CD4
+ T cells and DCs [48]. Qi et al. focused on B cells,
showing how they surveyed antigen-bearing DCs [49]. B
cells arrested on DCs and then induced intracellular calcium
signaling. This interaction seemed to be important for
antibody production, but not for germinal center formation.
The same group demonstrated that the B–T cell interaction
was necessary for the formation of a germinal center [50].
After T cells are stimulated in contact with antigen-
presenting cells, T cells get activated. One of earliest
hallmarks of activation is calcium influx. Bhakta et al.
visualized calcium oscillations in the T cell [51]. They used
thymic acute slices incubated with T cells that were labeled
with calcium indicator. They nicely illustrated highly motile
cells at low intracellular calcium concentration whereas
arrested T cells after calcium spikes. Wei et al. showed
similar founding that antigen/MHC-complex-induced calci-
um spikes arrested T cell motility in the explanted lymph
node [52].
Two-photon imaging has also been used for subcellular
resolution imaging. For example, Wei et al. [52] visualized
intracellular calcium influx using CD4
+ T cells within
lymph node explants. They demonstrated that CD4
+ T cells
showed infrequent calcium spikes without specific antigen
encounters. In contrast, T cells engaged with APCs
presenting specific antigen showed an increased frequency
of calcium spikes. These spikes persisted for hours
independently of any contact with APCs. Other subcellular
imaging studies were carried out by Dustin’s group [53–
56], who visualized a highly organized molecular distribu-
tion at the point of contact between T cells and APCs. This
structure was called an immunological synapse, since it
resembles neuronal synapses. These studies gave first
valuable insights about the coordinated molecular rear-
rangements at the interface between T cell and APC in the
course of T cell receptor signaling.
Intravital TPLSM of autoaggressive effector T cells
In the following, we want focus on recent findings about
the in vivo behavior of brain antigen-reactive T cells. These
studies gave new insights about the questions on how
encephalitogenic T cells get access to the CNS and how
these T cells interact with resident cells to initiate
deleterious inflammation of the CNS tissue.
Ourmicroscopysetupconsistsofacommerciallyavailable,
tunable, pulsed two-photon laser system (Fig. 1c). A diode-
pumped laser generates 10 W of continuous laser from Nd:
YVO4 crystals with a wavelength of 532 nm. This green
laser is routed to Ti:sapphire laser, which converts the
wavelength from 532 nm into femtosecond light pulses of
700–1,050-nm wavelength. The excitation wavelengths
were tuned to the optimal excitation spectra of the used
fluorochromes (Table 1), e.g., for the GFP/RFP combination,
the laser was set to 935 nm. The laser power was controlled
by an electrical optic modulator (EOM). A galvano mirror
was employed for the xy scan of the tissue sample. The
upright microscope was equipped with a 20-fold water
immersion objective lens with a high numeric aperture
(N.A. 0.95). Non-descanned detectors placed close to the
objectiveensuredefficientsamplingoftheemittedfluorescent
light (Fig. 1c). Up to four colors could be detected at the
same time.
Animals were orotracheally intubated and anesthetized
by isofluorane ventilation (concentration 1–2%).
Fluorescence-labeled dextrans for visualization of blood
vessels were injected i.v. via catheterization of the tail vein.
For preparation of a spinal cord window, a 2–3-cm incision
of the skin on the lumbar spine was performed, and the
paravertebral musculature was removed. Thereafter, each
animal was fixed stereotactically on a custom-made table.
A laminectomy was carefully performed on one disk of the
lumbar spinal cord (L1), leaving the dura intact. During the
intravital recordings, physiological parameters, i.e., body
temperature, blood gasses, pulse, and electrocardiogram
(ECG), were constantly monitored. Images were acquired
from an area typically 600 μm×600 μm at a depth of 30–
50 μm( 3 –5-μm z-step). Repeated scanning and averaging
were performed to minimize noise. Each scan took approxi-
mately 1.3 s per plane, yielding a total time interval of
approximately 31 s. Using knock-out mice Kim et al. found
that the chemokine receptor CXCR6 was not crucial for the
formation of T cellular infiltrates during EAE [57]. Imaging
in this study was performed through the intervertebral spaces
280 Semin Immunopathol (2010) 32:275–287of the thoracic spine to avoid potential artifacts caused by
the complete laminectomy. Comparing these preparation tech-
niques we did not find significant changes in T cell loco-
motion pattern in early EAE lesions [28].
Intravascular T cell behavior in the CNS had been
studied using intravital fluorescence microscope. Kerfoot et
al. observed rolling and adhesion of leukocytes in brain
postcapillary venules before onset of physical symptoms of
MOG-induced EAE in the mouse [58]. Additionally, they
indicated that leukocyte–endothelial cell interaction is
P-selection/integrin α4 dependent although they did not
specify the leukocytes populations. At the same time,
Piccio et al. showed that PLP-specific T cells rolled and
arrested on the preactivated endothelial cells [59]. They
showed importance of selectins/integrins for the interaction.
Engelhardt and colleagues employed intravital imaging of
encephalitogenic T cells at the BBB [60]. In these studies,
activated proteolipid protein-reactive T cell blasts of SJL/N
mice were infused intra-arterially, and the migratory behavior
of T cells arriving in pial vessels of the spinal cord was
analyzed immediately after the T cell injection with a
fluorescence video microscope. These newly arriving T cells
did not roll along the inner endothelium before getting
attached. Instead, they became immediately firmly arrested
and penetrated into the CNS parenchyma within hours after
T cell transfer. The process of getting cells arrested on the
luminal endothelium was dependent on very late activation
antigen 4 (VLA-4)/VCAM-1 interactions, i.e., blocking
antibodies reduced significantly the number of adhering
and transmigrating T cells [61]. In a recent study, Bauer et al.
confirmed that integrin-binding forces were essential for this
behavior: integrin-β1-deficient murine T cells lacked the
capacity to firmly adhere to CNS microvessels [62].
An unexpected locomotion pattern at the BBB:
intraluminal T cell crawling
We investigated the migratory behavior of brain antigen
(MBP)-specific T cells in vivo during transfer EAE of the
Lewis rat. In contrast to preceding studies where T cells
wereinjectedintotheCNSarteriesandexaminedimmediately
after transfer of the activated T cell blasts, we transferred
activated T cells i.v. and observed their behavior in vivo for
several days. T cells arrived at the BBB after i.v. transfer as
postactivated migration-competent effector T cells, i.e., after
they had proceeded along distinct migratory paths through
secondary lymphatic organs during the preclinical phase of
EAE. The effector T cells underwent profound functional
changes on their way to the CNS [15]. This “migratory”
phenotype included downregulation of activation markers
(OX-40 antigen, interleukin (IL)-2 receptor, IFNγ,I L - 1 7 )
and upregulation of chemokine receptors (CCR5, CCR2).
Very few TMBP-GFP cells had arrived at leptomeningeal
vessels by 24 h p.t., i.e., 2 days before the onset of the
clinical disease. TMBP-GFP cells abounded in the vicinity of
blood vessels and moved for extended periods of time
along these vessels. TMBP-GFP cells flowing in the blood
stream were too fast to be detected by the TPLSM setting.
Rolling cells in these recordings resembled a rope of pearls
(Fig. 2b) because the images were averaged several times in
the same plane and, thus, one and the same cell was
recorded several times on its way at the intraluminal
endothelium. The numbers of arriving T cells very slowly
increased until 48–60 h p.t., and then we observed a sudden
accumulation of the T cells. Intriguingly, the vast majority
of the early arriving T cells crawled strictly within the
outline of vessels. Therefore, one of our goals was to
determine whether the TMBP-GFP cells were located inside
or outside the blood vessels. Several lines of evidence
showed that these TMBP-GFP cells indeed crawled along the
intraluminal surface of the vessels [28]. Some TMBP-GFP
cells were shown to arrive via the blood stream, and these
T cells started to crawl immediately after becoming
attached to the inner surface. Conversely, other T cells
were observed to be washed away by the blood stream after
they had spent some time crawling within the vessels. In
addition, some TMBP-GFP cells looked like spared black
a
b
Fig. 2 Intravital recording of TMBP-GFP cells (green) in vessels of the
CNS (a) and the ear (b). Vessels were marked by i.v. injection of
Texas Red dextran conjugates (red). Thirty-minute movies, consisting
of 60 time points, were time-projected. Crawling T cells appear as
continuous lines, whereas rolling cells appear as round-shaped dots.
Scale bar 30 μm
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switched off. Since TMBP-GFP cells do not take up the
dextran label floating within the blood stream, intraluminal
TMBP-GFP cells produce such dark spots, whereas extrava-
sated TMBP-GFP cells do not. Finally, a 3D reconstruction of
the recorded images revealed that indeed many of these
early arriving TMBP-GFP cells were located inside the
vessels.
Quantification of crawling vs. rolling cells revealed that
more than 80% of the observed TMBP-GFP cells crawled in
the CNS blood vessels. This locomotion behavior was
specific to leptomeningeal vessels (Fig. 2a). It was less
obvious in the vessels of connective ear tissue, cremasteric
muscles, or peripheral nerves (Fig. 2b). Mouse effector
T cells and long-lived rat memory/effector T cells were also
shown to crawl along the intraluminal surface of the CNS
vessels. Furthermore, this intraluminal crawling behavior
was not specific to autoantigen-specific T cells. T cells that
recognized ovalbumin (OVA; TOVA-GFP cells) showed a
similar pattern of intraluminal crawling. Notably, TOVA-GFP
cells crawled for a shorter time period than their pathogenic
counterparts. This was most likely due to the activation
state of the endothelium: after cotransfer of pathogenic
TMBP cells, the intraluminal crawling time of TOVA-GFP cells
significantly increased and was almost identical to that of
TMBP-GFP cells. The half-life of TMBP-GFP cell crawling was
approximately 15 min [28]. One can speculate with high
probability that the TMBP-GFP cells crawled extensively on
the inner surface of CNS vessels in order to spot a suitable
place for extravasation.
A closer analysis of the T cell motility at the CNS
vessels revealed some more interesting findings [28]. First,
intraluminal TMBP-GFP cells moved preferably in the
opposite direction to the blood flow. Approximately 40%
of analyzed cells moved against the blood flow. In contrast,
only 20% of the analyzed cells moved in the direction of
the blood stream. Extravasated cells did not show any
preferential direction. Then, even if intraluminal TMBP-GFP
cells moved against the blood flow, they moved as fast
as TMBP-GFP cells that moved with the blood flow. The
average motility of TMBP-GFP cells was 12 μm/min,
independent of their direction. The velocity of intraluminal
and extravasated cells was similar. However, intralumi-
nally migrating cells moved slightly faster (12.5 vs.
11.3 μm/min).
Intraluminal crawling is not a specialty of T cells.
Monocytes [63], NKT cells [64], and neutrophils [65] also
engage in intraluminal crawling. The molecular mechanism
of this crawling is not yet completely clear; however, LFA-
1 and CX3CR-1 molecules were described to mediate
crawling of macrophages, whereas Mac-1 was found to be
crucial in neutrophils. We found that VLA-4, but not LFA-
1, played an important role in the intraluminal crawling of
effector T cells. When anti-VLA-4 antibody was applied
i.v., intraluminally crawling TMBP-GFP cells detached them-
selves within minutes, and subsequent infiltration and
clinical symptoms were strongly reduced [28].
Extravasation followed intraluminal crawling. According
to our observations, intraluminally crawling cells stopped
abruptly and then immediately changed their shapes, as if
looking for an exit. When the place was found, they started to
extravasate, a process that took approximately 10–20 min
[28]. The detailed molecular mechanisms underlying diape-
desis are still unclear, but integrins and G-coupled proteins
were shown to contribute to T cell extravasation [62, 66].
Engelhardt et al. [67] suggested that there are two different
ways of extravasation, namely either paracellular migration,
during which Tcells pass through the tight junctions between
endothelial cells, or transcellular migration, during which
T cells pass though endothelial cells as in endocytosis and
exocytosis. It is yet to be clarified which of these two ways
characterize rat autoreactive T cells.
Encountering the gatekeepers in perivascular/meningeal
locations: a crucial checkpoint for parenchymal
invasion
It was known that once the effector T cells had overcome
the vascular barrier of the CNS vessels, they would become
reactivated, i.e., they expressed membranous activation
markers (OX-40 antigen and IL-2 receptor) and released
proinflammatory cytokines [15, 68]. The CNS, as well as
the eyes and the testes, are commonly considered immune-
privileged environments due to the lack of professional
APCs and lymphatic vessels [69]. Over the last decades,
however, this view has been challenged. For example, it
turned out that, upon stimulation with proinflammatory
cytokines, soluble mediators, such as chemokines and
cytokines, as well as MHC determinants can be induced
on many, if not all, brain cells [70]. However, it still
remains open which cell type accounts for the reactivation
of effector T cells freshly arriving at the naive BBB.
Perivascular/meningeal macrophages are known to consti-
tutively express MHC class II molecules and to present
endogenous autoantigens [71]. Indeed, our intravital imag-
ing studies hinted to a crucial role of this phagocyte
population in the activation process of T cells.
Our intravital recordings also revealed that TMBP-GFP
cells after diapedesis stayed in the vicinity of the blood
vessels and continued to crawl on the abluminal surface. A
quantitative analysis showed that freshly extravasating
Tcells spend 80% of their time in the perivascular locations
[28]. Because TMBP-GFP cells were activated immediately
after leaving the blood circulation, we hypothesized that
TMBP-GFP cells were activated in the perivascular locations
282 Semin Immunopathol (2010) 32:275–287when they come in contact with resident APCs. Previous
studies demonstrated that in the perivascular area of
leptomeningeal vessels there are indeed potential APCs.
These APCs were found to be radiosensitive [71]. To make
these cells visible for TPLSM, we therefore prepared bone
marrow chimeras, in which bone marrow cells derived from
GFP transgenic rats [21] were grafted into lethally
irradiated wild-type recipient rats. The animals were kept
at least 10 weeks to allow sufficient replacement of the
perivascular cells and were then used in the experiments
[72]. Alternatively, we injected fluorescent-conjugated
dextran intrathecally into the cisterna magna to light up
the phagocytic cells in the CNS perivascular areas and the
meninges. Both methods stained a similar population of
cells. Although the number of labeled phagocytic cells
exceeded those of bone-marrow-derived cells, we con-
firmed that the majority (>90%) of bone-marrow-derived
cells were labeled with intrathecally injected dye. TMBP-RFP
cells were used in the intravital imaging of GFP bone
marrow chimeras. Substantial parts of TMBP-GFP/RFP cells
showed both long stable (>10 min) and multiple short
(<10 min) contacts to labeled perivascular macrophages
[28]. T cells and dendritic cells in lymph nodes showed
similar long- and short-term interactions during intravital
imaging, although in a chronologically sequential order
[27]. The contact durations in the perivascular/meningeal
areas varied at different stages of the autoimmune process:
a short series of contacts occurred in the early EAE states,
whereas long-lasting contacts became more prominent at a
later stage. The meaning of these different contact durations
is currently being investigated. Interestingly, not all of the
infiltrated TMBP-GFP cells made stable contacts to antigen-
presenting cells (maximally 30–40%) [28]. When soluble
MBP was applied intravenously, our intravital recording
showed a dramatic increase of arrested TMBP-GFP cells
(>70%) [73]. This indicates that, even during full-blown
disease, the antigen-presenting cells in the CNS are not
saturated by endogenous autoantigens.
Following their perivascular accumulation and making
contacts with potential APCs, TMBP-GFP cells detached
themselves from the blood vessels and migrated freely into
the CNS meninges. Furthermore, some T cells started to
distribute themselves within the CNS parenchyma [28].
Although T cell–APC contacts and T cell penetration into
the CNS occurred, no direct evidence was found for a
causal relation between these events. Since TMBP-GFP cells
recognize endogenous MBP-presenting APCs, it was
difficult to observe the entire process from antigen
recognition to penetration into the CNS. To prove that
antigen presentation at the perivascular/meningeal level was
sufficient to activate the T cells and their migration, we
analyzed the conditions under which brain antigen-ignorant
TOVA-GFP cells would invade the CNS parenchyma.
TOVA-GFP cells arrive at the vessels of the CNS
meninges, but they never spontaneously penetrate in
detectable numbers into the parenchyma [15] although a
few cells were observed at the perivascular area [28]. To
prove the importance of antigen presentation at this
location, perivascular/meningeal APCs, which were fed
before with ovalbumin, were applied intrathecally into
animals 3 days after the transfer of TOVA-GFP cells. The
APCs had been prepared from CNS meninges of naïve
Lewis rats by flow cytometric sorting of fluorochrome-
conjugated dextran-labeled cells. These APCs carry
markers of macrophages, i.e., they expressed CD11b but
not CD11c (dendritic cell marker), T cell receptor, OX-33
(B cell marker), or RECA1 (endothelial cell marker). Most
importantly, more than half of these labeled cells expressed
MHC class II and could stimulate T cells in an antigen-
specific manner in vitro. Intriguingly, the OVA-pulsed APC
recruited high numbers of TOVA-GFP cells into CNS
parenchyma. Additionally, intravital recording revealed that
TOVA-GFP cells after transfer of the OVA-pulsed APC got
arrested to the cells and developed signs of efficient
reactivation. Furthermore, OVA-pulsed APC-treated ani-
mals revealed mild clinical symptoms, i.e., they suffered
significant weight loss. These data provide strong evidence
that APCs located in perivascular/meningeal locations are
able to activate antigen-specific T cells and to recruit them
into the CNS parenchyma, which is followed by the onset
of clinical symptoms (Fig. 3)[ 28].
The above studies indicate that T cells infiltrate the CNS
parenchyma via meningeal vessels. In contrast, Reboldi et
al. provided evidence for an alternative path via vessels of
the choroid plexus [74]. Using CCR6 knockout mice,
which are resistant to EAE, they made two findings. First,
they found that CCL20, a CCR6 ligand, was expressed in
epithelial cells of the choroid plexus in mice and humans.
Furthermore, lymphocytes were found to accumulate at the
choroid plexus in CCR6-deficient mice. Taken together,
they suggested that Tcells initially start to penetrate into the
CNS via the choroid plexus in a CCL20-CCR6-dependent
manner. Additionally, they reconstituted EAE susceptibility
by transferring wild-type T cells; afterwards, even CCR6-
deficient T cells penetrated into the CNS. This result
suggested that CCR6 plays an important role in the
initiation of the disease, but once the blood brain barrier
is disrupted, other T cells pass into the CNS independently
of CCR6.
TMBP-GFP cell motility deep within the CNS parenchyma
Due to limited penetration depth, TPLSM is not suitable for
obtaining images deep inside the CNS parenchyma.
Therefore, CNS explants were imaged [75]. CNS acute
Semin Immunopathol (2010) 32:275–287 283slices with a thickness of 300 μm were prepared from the
acute phase of EAE rats. Explants were placed in custom-
made chambers in which temperature-controlled oxygen-
enriched buffer was constantly perfused. This setting
allowed us to visualize T cell motility within the CNS
parenchyma for a number of hours.
TMBP-GFP cells moved very fast in the CNS parenchyma,
reaching velocities of maximally 25 μm/min, i.e., they
traveled almost as fast as T cells in the lymph nodes [37].
This finding was surprising if one considers the compact-
ness and the highly structured composition of the CNS
parenchyma, which lack preformed “roads” for immune
cells. The T cells moved in all directions, apparently
ignoring chemokine gradients, although chemokines might
exert an influence in microenvironments. The cells do not
move spontaneously but rather moved in a “stop-and-go”
mode, which suggested a possible interaction with local
structures. Two types of T cell motility were found: motile
and stationary. Two thirds of the cells showed the motile
phenotype, moving more than 10 μm in 10 min. Mean
displacement analysis revealed that they exhibited a
“random walk.” The remaining cells showed the stationary
phenotype, their locomotion being highly confined. These
effector T cells seemed to be anchored at a fixed point and
moved the rest of their cell body around this fixation. Some
motile cells changed to stationary or vice versa.
WespeculatedthatthestationaryTcellswereintheprocess
of antigen recognition, whereas motile cells were on the
search for APCs presenting their antigen. Several arguments
supported this hypothesis. First, TOVA-GFP cells recruited into
the CNS parenchyma by cotransfer of TMBP-GFP cells
showed hardly any stationary phenotype, most likely since
ovalbumin is not presented within the CNS tissue. Second,
TOVA-GFP cells became arrested in the CNS parenchyma,
when ovalbumin was provided to APCs of the spinal cord.
Inversely, the numbers of stationary TMBP-GFP cells were
reduced when neutralizing anti-MHC class II monoclonal
antibody was applied in the CNS. Third, stationary cells
were observed to make immunological synapses [53, 76, 77]
and move around their anchor point. These results strongly
suggest that the cells were stationary during the process of
antigen recognition.
Antigen recognition preceded Tcell activation, which was
followed by the production of inflammatory chemokines,
including TNFα,M I P 1 α, and MCP1. Only activated T cells
produce these chemokines. For example, low-pathogenic
S100β or MOG-specific T cells, which are not/insufficiently
activated in the CNS, did not produce these inflammatory
T cell MBP-GFP perivascular macrophage
endothelial cell
blood vessel
1. rolling 2. intraluminal crawling
3. extravasation
4a. extraluminal
crawling
5a. activation
in meninges
5b. activation in the
parenchyma
6. penetration to parenchyma
subarachnoidal vessels
4b. extraluminal
crawling to the
RV space
blood flow
meningeal macrophage
7. activation within parenchyma
APCs in the parenchyma
Fig. 3 Schema of the invasion steps of TMBP-GFP cells into the CNS
parenchyma. TMBP-GFP cells arrive at CNS leptomeningeal vessels and
roll on endothelial cells (1). This is followed by intraluminal crawling
directed both upstream and downstream of blood flow (2). After the
extravasation (3), TMBP-GFP cells continue to crawl to the abluminal
surface of vessels (4a). A part of T cells dive to the Robin Virchow
space (RV; 4b). T cells meet local antigen-presenting cells at the
perivascular space of leptomeningeal vessels (5a) or parenchyma (5b)
and are activated. Activated T cells are allowed to penetrate within the
CNS parenchyma (6). Finally, T cells can be further activated by
antigen-presenting cells in the CNS parenchyma (7)
284 Semin Immunopathol (2010) 32:275–287cytokines [68] although both types of T cells could penetrate
into the CNS. The upregulated inflammatory cytokines
recruit macrophages, which contributed to the development
of EAE clinical symptoms.
Outlook for the future
Recent developments in technical instruments and fluo-
rescent reporter dyes and technologies now provide
researchers with previously unimagined possibilities.
Intravital imaging by two-photon microscopy started
with the observation of a single-cell population, i.e.,
lymphocytes, in organ explants. Soon thereafter, tracking
of interactions between several cell types, e.g., T cells
and dendritic cells, became feasible. Imaging proceeded
to intravital imaging at greater depth and for longer
periods of observation. Since multicolor imaging in the
living animal has become standard, many advances have
been made in imaging, for example high-resolution
imaging for evaluation of cell function, e.g., calcium
signaling, and molecular interaction in the cells. Obvi-
ously, each new advance can provide new insights into
cells and mechanisms of disease. In summary, intravital
imaging has led to a better understanding of immune cell
behavior and function in vivo. Studies employing novel
or established therapeutic agents, such as anti-VLA-4
antibodies, might additionally add to the development of
safer and more targeted therapeutic approaches for
autoimmune-mediated diseases.
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